Código QR (código de barras bidimensional)

The efficacy and safety of Radiofrequency ablation combined with Lenvatinib plus Sintilimab in Unresectable Hepatocellular Carcinoma: a real-world study

Abstract Background The combination of targeted therapy and immunotherapy has improved the clinical outcomes of unresectable hepatocellular Carcinoma (HCC). However, the overall prognosis remains suboptimal. This study aims to evaluate the efficacy and safety of a novel combination of radiofrequency...

ver descrição completa

Na minha lista:
Principais autores: Xishu Wang, Ximin Sun, Yongrong Lei, Lingyan Fang, Yuedi Wang, Kai Feng, Feng Xia
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2024-08-01
coleção:BMC Cancer
Assuntos:
Unresectable hepatocellular carcinoma
Radiofrequency ablation
Lenvatinib
Sintilimab
Locoregional therapy
Acesso em linha:https://doi.org/10.1186/s12885-024-12779-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados